Treponema Mosaic

Treponema pallidum Mosaic Recombinant
Shipped with Ice Packs
In Stock

Description

Applications in Immunoassays

Treponema Mosaic is optimized for serological testing, including enzyme-linked immunosorbent assays (ELISAs). Its multi-epitope design addresses limitations of single-antigen assays by:

  • Improving Sensitivity: Combining epitopes from distinct antigens enhances detection of diverse antibody responses .

  • Reducing Cross-Reactivity: By focusing on T. pallidum-specific regions (e.g., TP47), it minimizes false positives from non-syphilitic treponematoses .

Example Performance Metrics (from related studies):

AntigenIgM ELISA SensitivityIgG ELISA SensitivitySpecificity
Tp082191.0%98.3%94.3–100%
Treponema MosaicN/A (analogous to multi-epitope designs)N/AHigh (deduced from TP47’s specificity)

While direct data on Treponema Mosaic’s performance is limited, analogous multi-antigen constructs demonstrate superior diagnostic accuracy compared to single-protein tests .

Diagnostic Challenges

  • Immune Evasion: T. pallidum’s outer membrane has <50 integral proteins, making surface antigens scarce . The use of periplasmic lipoproteins (e.g., TP15, TP17) compensates for this limitation .

  • Cross-Reactivity: Non-treponemal tests (e.g., VDRL) often yield false positives. Treponema Mosaic’s focus on T. pallidum-specific epitopes mitigates this issue .

Comparative Analysis of Epitope Components

EpitopeGene IDLocalizationFunctionDiagnostic Relevance
TP15TP0171Periplasmic membraneLipoprotein (adhesion?)High immunogenicity in early syphilis
TP17TP0435Periplasmic membraneLipoprotein (unknown)Reactivity in chronic infections
TP47TP0574Periplasmic membraneTpp47 (ABC transporter substrate)Conserved epitope for serological assays

Key Observations:

  • TP47 is a validated target in modern diagnostics due to its role in metal transport and conserved structure .

  • TP15/TP17 are less characterized but contribute to broader epitope coverage, critical for detecting diverse antibody responses .

Future Directions

  • Vaccine Development: While Treponema Mosaic is diagnostic-focused, its epitopes could inform vaccine candidates targeting T. pallidum’s conserved regions .

  • Next-Generation Diagnostics: Coupling Treponema Mosaic with point-of-care platforms (e.g., rapid tests) may enhance accessibility in resource-limited settings .

Product Specs

Introduction
Treponema pallidum, a gram-negative spirochaete bacterium with limited metabolic capabilities, is known to have at least four subspecies: T. pallidum pallidum, T. pallidum pertenue, T. pallidum carateum, and T. pallidum endemicum. Its helical structure enables corkscrew motion through viscous substances like mucus. The subspecies pallidum, with a small genome of 1.14 million base pairs, exhibits reduced metabolic abilities, indicating adaptation to the nutrient-rich environment of mammalian tissue.
Description
Recombinant Treponema pallidum Mosaic is a 38kDa protein comprising TP15, TP17, and TP47 epitopes. Produced in E. coli, it encompasses 382 amino acids and features a C-terminal 6xHis tag. Purification is achieved through proprietary chromatographic techniques.
Physical Appearance
Sterile Filtered solution.
Formulation
Treponema Mosaic protein solution is formulated in 1x PBS and 25mM K2CO3.
Stability
For optimal stability, Treponema Mosaic protein should be stored below -18°C. While it can remain stable at 4°C for a week, freeze-thaw cycles should be avoided.
Applications
Immunoassay.
Purity
Treponema Mosaic exhibits a purity greater than 95%, as determined by 10% PAGE (coomassie staining).
Source
Escherichia Coli.

Q&A

What is the significance of the mosaic genomic structure observed in Treponema pallidum subspecies?

The mosaic genomic structure in Treponema pallidum subspecies, particularly between Treponema pallidum ssp. pallidum (TPA) and Treponema pallidum ssp. pertenue (TPE), is significant because it provides insights into the mechanisms of horizontal gene transfer and evolutionary adaptation in pathogenic bacteria. Mosaic loci such as TPAMA_0326 (tp92) and TPAMA_0488 (mcp2-1) exhibit sequences derived from both TPA and TPE strains, suggesting inter-strain recombination during simultaneous infection within a single host . This genomic blending may confer selective advantages, such as immune evasion or altered tissue tropism, which are critical for survival and pathogenicity.

Methodologically, researchers can study mosaic structures using comparative genomics approaches. Techniques like whole genome sequencing (e.g., Illumina sequencing) followed by annotation and codon-based testing for positive selection are essential for identifying recombination events and understanding their functional implications .

How can researchers design experiments to investigate the functional impact of mosaic loci in Treponema pallidum?

Experimental design for studying the functional impact of mosaic loci should integrate molecular biology techniques with immunological assays. For instance:

  • Gene Expression Studies: Clone mosaic genes such as TPAMA_0326 or TPAMA_0488 into expression vectors and assess their protein products in bacterial or mammalian systems.

  • Protein Structure Analysis: Use computational modeling and X-ray crystallography to determine whether the mosaic sequences alter protein folding or function, particularly in domains like β-barrel structures or Cache domains .

  • Immune Response Assays: Evaluate whether mosaic proteins elicit differential antibody or T-cell responses compared to non-mosaic variants using ELISA or flow cytometry.

  • Host-Pathogen Interaction Studies: Infect animal models with recombinant strains containing mosaic genes to observe changes in tissue tropism, virulence, or immune evasion capabilities.

These experiments require rigorous controls to distinguish the effects of mosaic sequences from other genomic variations.

What methodologies are used to detect horizontal gene transfer events in Treponema pallidum?

Horizontal gene transfer (HGT) events can be detected using several methodologies:

  • Comparative Genomics: Align whole genome sequences from multiple strains (e.g., TPA Mexico A, Nichols, SS14) to identify loci with mixed nucleotide patterns indicative of recombination .

  • Phylogenetic Analysis: Construct phylogenetic trees for specific genes to trace evolutionary relationships and detect incongruences suggestive of HGT.

  • Mismatch Repair Studies: Investigate DNA repair mechanisms that may facilitate HGT by analyzing genes like mutS and mutL, which are annotated in the TPA genome .

  • Experimental Transformation: Introduce foreign DNA into bacterial cultures under controlled conditions to observe integration patterns similar to those seen in natural HGT.

These methods provide a comprehensive framework for studying genetic exchange between treponemal subspecies.

How do mosaic loci influence the growth potential of Treponema pallidum strains under laboratory conditions?

The presence of mosaic loci can impact the growth potential of Treponema pallidum strains in vitro. For example, the TPA Mexico A strain exhibits lower growth potential compared to other TPA strains like Nichols or SS14 . This reduced growth may be linked to selective pressures exerted by host immunity during natural infection, where mosaic loci provide advantages such as immune evasion but compromise replication efficiency outside the host environment.

To study this phenomenon experimentally:

  • Conduct growth assays comparing wild-type strains with recombinant strains containing mosaic loci.

  • Analyze metabolic pathways affected by mosaic sequences using transcriptomics or proteomics.

  • Investigate interactions between mosaic proteins and host factors that may limit bacterial proliferation.

Understanding these dynamics is crucial for interpreting laboratory findings within the context of natural infections.

What role do positive selection pressures play in shaping mosaic genomic structures?

Positive selection pressures drive the evolution of mosaic genomic structures by favoring genetic variants that enhance survival under specific environmental conditions. In Treponema pallidum, codon-based tests have revealed that genes TPAMA_0326 (tp92) and TPAMA_0488 (mcp2-1) are under positive selection both within TPA strains and between TPA and TPE strains . These pressures may arise from:

  • Host immune responses targeting bacterial surface proteins.

  • Tissue-specific factors influencing bacterial tropism.

  • Competition between co-infecting treponemal subspecies.

Researchers can study positive selection using methods such as:

  • dN/dS ratio calculations to quantify selective pressure on coding regions.

  • Site-specific mutagenesis followed by functional assays to determine adaptive benefits.

  • Comparative analysis of homologous genes across related species.

These approaches provide insights into how genetic diversity contributes to pathogenicity.

How can researchers resolve data contradictions when studying treponemal genomes?

Resolving data contradictions requires a systematic approach:

  • Cross-validation: Compare findings across multiple datasets generated using different sequencing platforms (e.g., Illumina vs. PacBio).

  • Reanalysis: Reanalyze raw data using updated bioinformatics tools to eliminate errors introduced by outdated algorithms.

  • Replication: Perform independent experiments to confirm controversial results, such as discrepancies in nucleotide positions within mosaic loci.

  • Collaborative Studies: Collaborate with other researchers working on treponemal genomics to pool resources and expertise for resolving conflicts.

For example, discrepancies regarding nucleotide changes at TPAMA_0326 or TPAMA_0488 loci can be addressed by integrating data from published studies with new experimental results .

What implications do treponemal mosaics have for vaccine development?

The mosaic nature of treponemal genomes poses challenges for vaccine development due to antigenic variability:

  • Mosaic proteins like TPAMA_0326 exhibit structural features that may evade antibody recognition .

  • Positive selection on surface-exposed loops suggests adaptive changes aimed at immune evasion .

To overcome these challenges:

  • Focus on conserved regions within mosaic proteins that are less prone to variability.

  • Develop multivalent vaccines targeting multiple antigenic variants simultaneously.

  • Use reverse vaccinology approaches to identify epitopes capable of eliciting broad immune responses.

These strategies require detailed knowledge of treponemal immunology and genomics.

How can researchers study tissue tropism changes associated with treponemal mosaics?

Changes in tissue tropism associated with treponemal mosaics can be studied using:

  • Animal Models: Infect animals with wild-type and recombinant strains containing specific mosaic loci to observe differences in tissue colonization patterns.

  • In Vitro Assays: Use cell culture systems mimicking human tissues (e.g., epithelial cells) to assess bacterial adherence and invasion capabilities.

  • Transcriptomic Analysis: Compare gene expression profiles between strains exhibiting distinct tropisms to identify regulatory pathways influenced by mosaics.

  • Small Molecule Binding Studies: Investigate Cache domain functions in TPAMA_0488 proteins using ligand binding assays .

These studies provide critical insights into how genetic recombination affects host-pathogen interactions.

Product Science Overview

Recombinant Proteins in Syphilis Diagnosis

Recombinant proteins are artificially produced proteins that are used in various diagnostic and therapeutic applications. In the context of Treponema pallidum, several recombinant proteins have been developed to improve the accuracy of syphilis diagnosis. These proteins include TmpA, TpN17, and TpN47, which have shown varying degrees of sensitivity and specificity in serological tests .

  • TmpA: This protein has shown high specificity but lower sensitivity in serological tests.
  • TpN17: Known for its high specificity and moderate sensitivity, making it a reliable marker in syphilis diagnosis.
  • TpN47: Exhibits the highest accuracy among the tested recombinant proteins, with high sensitivity and specificity .
Mosaic Recombinant Proteins

Mosaic recombinant proteins are engineered by combining sequences from different strains or variants of a pathogen. This approach aims to create a more comprehensive antigen that can elicit a stronger immune response or improve diagnostic accuracy. In the case of Treponema pallidum, mosaic recombinant proteins are designed to include epitopes from multiple strains, enhancing their ability to detect diverse variants of the bacterium .

Applications and Implications

The development of mosaic recombinant proteins for Treponema pallidum has significant implications for both diagnostics and vaccine development. By incorporating multiple epitopes, these proteins can improve the sensitivity and specificity of serological tests, leading to more accurate diagnoses. Additionally, they hold promise for the development of a universal syphilis vaccine that can provide broad protection against various strains of the bacterium .

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2024 Thebiotek. All Rights Reserved.